Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: Effect on myocardial ischemia and need for coronary revascularization
- 1 December 1992
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 124 (6) , 1419-1426
- https://doi.org/10.1016/0002-8703(92)90052-w
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Very early thrombolytic therapy in suspected acute myocardial infarctionThe American Journal of Cardiology, 1990
- Angiographic observations and clinical relevance of coronary thrombus in unstable angina pectorisThe American Journal of Cardiology, 1989
- Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromesThe American Journal of Cardiology, 1989
- Angiographic morphology in unstable angina pectorisThe American Journal of Cardiology, 1988
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Coronary thrombosis, coronary spasm and coronary atherosclerosis and speculation on the link between unstable angina and acute myocardial infarctionThe American Journal of Cardiology, 1987
- Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trialsEuropean Heart Journal, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- TRIAL OF HEPARIN VERSUS ATENOLOL IN PREVENTION OF MYOCARDIAL INFARCTION IN INTERMEDIATE CORONARY SYNDROMEThe Lancet, 1981